Inhibitory Effects of Evodiamine on Human Osteosarcoma Cell Proliferation and Apoptosis

Overview

Journal Oncol Lett

Specialty Oncology

Date 2015 Jan 27

PMID 25621054

Citations 9

Authors

Xiaodong Bai

Hai Meng

Lifeng Ma

Ai Guo

Affiliations

Soon will be listed here.

Abstract

Osteosarcoma is a primary malignancy of bone, which is characterized by the proliferation of malignant mesenchymal cells, particularly in children and adolescents. Evodiamine is extracted from a variety of traditional Chinese medicines, which has been reported to induce apoptosis in certain tumors, including cervical, prostate and breast cancer, however, its effect on oestosarcoma cells remains unclear. The aim of the present study was to investigate the effect of evodiamine on osteosarcoma cell proliferation and apoptosis, and explore the associated underlying molecular mechanism. A Cell Counting Kit 8 assay was performed to detect the effects of evodiamine on the proliferation of human osteosarcoma U2OS cells. Annexin V-fluorescein isothiocyanate/propidium iodide staining was performed to analyze the apoptotic rate of the cells. The effect of evodiamine on the protein expression levels of B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), caspase-3 and survivin were detected by performing western blot analysis. Evodiamine inhibited the growth of human osteosarcoma U2OS cells by inhibiting cell proliferation and inducing cell apoptosis. Western blotting demonstrated that evodiamine downregulated the expression of Bcl-2, caspase-3 and survivin, and upregulated the expression of Bax in human osteosarcoma cells. Evodiamine effectively inhibited proliferation and induced apoptosis of osteosarcoma cells in a dose-dependent manner via downregulation of Bcl-2, caspase-3 and survivin protein expression levels and upregulation of Bax protein expression levels.

Citing Articles

Enhancing apoptosis-mediated anticancer activity of evodiamine through protein-based nanoparticles in breast cancer cells.

Solanki R, Rajput P, Jodha B, Yadav U, Patel S Sci Rep. 2024; 14(1):2595.

PMID: 38297059 PMC: 10830498. DOI: 10.1038/s41598-024-51970-3.

Traditional Medicinal Plants as a Source of Inspiration for Osteosarcoma Therapy.

Kazantseva L, Becerra J, Santos-Ruiz L Molecules. 2022; 27(15).

PMID: 35956961 PMC: 9370649. DOI: 10.3390/molecules27155008.

Research progress on evodiamine, a bioactive alkaloid of : Focus on its anti-cancer activity and bioavailability (Review).

Luo C, Ai J, Ren E, Li J, Feng C, Li X Exp Ther Med. 2021; 22(5):1327.

PMID: 34630681 PMC: 8495584. DOI: 10.3892/etm.2021.10762.

Effects of Holothurian Glycosaminoglycan on the Sensitivity of Lung Cancer to Chemotherapy.

Lin C, Zhu X, Jin Q, Sui A, Li J, Shen L Integr Cancer Ther. 2020; 19:1534735420911430.

PMID: 32202167 PMC: 7092648. DOI: 10.1177/1534735420911430.

Evodiamine inactivates NF-κB and potentiates the antitumor effects of gemcitabine on tongue cancer both in vitro and in vivo.

Guo Q, Liu Y, Zhao J, Li Y, Pang Y, Chen J Onco Targets Ther. 2019; 12:257-267.

PMID: 30643424 PMC: 6312051. DOI: 10.2147/OTT.S181062.

References

Kan S, Yu C, Pu H, Hsu J, Chen M, Wang P . Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. J Cell Biochem. 2007; 101(1):44-56. DOI: 10.1002/jcb.21036. View

Fei X, Wang B, Li T, Tashiro S, Minami M, Xing D . Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells. Cancer Sci. 2003; 94(1):92-8. PMC: 11160161. DOI: 10.1111/j.1349-7006.2003.tb01358.x. View

Yang J, Liu X, Bhalla K, Kim C, Ibrado A, Cai J . Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997; 275(5303):1129-32. DOI: 10.1126/science.275.5303.1129. View

Zhang Y, Wu L, Tashiro S, Onodera S, Ikejima T . [Evodiamine induces A375-S2 cell death through two different pathways]. Yao Xue Xue Bao. 2004; 38(9):650-3. View

Altieri D . Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 2007; 8(1):61-70. DOI: 10.1038/nrc2293. View

Suzuki A, Shiraki K . Tumor cell "dead or alive": caspase and survivin regulate cell death, cell cycle and cell survival. Histol Histopathol. 2001; 16(2):583-93. DOI: 10.14670/HH-16.583. View

Salah S, Ahmad R, Sultan I, Yaser S, Shehadeh A . Osteosarcoma with metastasis at initial diagnosis: Current outcomes and prognostic factors in the context of a comprehensive cancer center. Mol Clin Oncol. 2014; 2(5):811-816. PMC: 4106734. DOI: 10.3892/mco.2014.325. View

Ohtsuka T, Buchsbaum D, Oliver P, Makhija S, Kimberly R, Zhou T . Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway. Oncogene. 2003; 22(13):2034-44. DOI: 10.1038/sj.onc.1206290. View

Huang Y, Guh J, Teng C . Induction of mitotic arrest and apoptosis by evodiamine in human leukemic T-lymphocytes. Life Sci. 2004; 75(1):35-49. DOI: 10.1016/j.lfs.2003.11.025. View

10.

Mirabello L, Troisi R, Savage S . Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009; 115(7):1531-43. PMC: 2813207. DOI: 10.1002/cncr.24121. View

11.

Hockenbery D, Oltvai Z, Yin X, Milliman C, Korsmeyer S . Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993; 75(2):241-51. DOI: 10.1016/0092-8674(93)80066-n. View

12.

Antonsson B . Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion. Cell Tissue Res. 2001; 306(3):347-61. DOI: 10.1007/s00441-001-0472-0. View

13.

SWANTON E, Savory P, Cosulich S, Clarke P, Woodman P . Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts. Oncogene. 1999; 18(10):1781-7. DOI: 10.1038/sj.onc.1202490. View

14.

Chiou W, Chou C, Shum A, Chen C . The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action. Eur J Pharmacol. 1992; 215(2-3):277-83. DOI: 10.1016/0014-2999(92)90039-7. View

15.

Jiang J, Hu C . Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa. Molecules. 2009; 14(5):1852-9. PMC: 6254303. DOI: 10.3390/molecules14051852. View

16.

Liao C, Pan S, Guh J, Chang Y, Pai H, Lin C . Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. Carcinogenesis. 2005; 26(5):968-75. DOI: 10.1093/carcin/bgi041. View

17.

Tamm I, Wang Y, Sausville E, Scudiero D, Vigna N, Oltersdorf T . IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998; 58(23):5315-20. View

18.

Fiandalo M, Kyprianou N . Caspase control: protagonists of cancer cell apoptosis. Exp Oncol. 2012; 34(3):165-75. PMC: 3721730. View

19.

Lin S, Liu J, Chang H, Yeh S, Lin C, Lee W . Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J Cell Biochem. 2002; 84(3):532-44. View

20.

Kan S, Huang W, Lin L, Wang P . Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Int J Cancer. 2004; 110(5):641-51. DOI: 10.1002/ijc.20138. View